Biotech

All Articles

Biogen's CEO stated no dangerous handle 2023. He's ready to become daring

.While Biogen's pharma peers are looking for late-stage resources along with little bit of danger, C...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has actually been a biotech seeking a pipeline after it ditched its own lead asset...

Biogen ignores Denali Alzheimer's collab

.Biogen has returned civil rights to a very early Alzheimer's condition course to Denali Therapies, ...

Takeda touches brand-new mind people oncology organization-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Vertex, beaten through AATD once again, goes down 2 properties on dispose of heap

.Vertex's effort to treat an unusual genetic health condition has struck an additional trouble. The ...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Medical's second-quarter revenues file had not been except huge information. The business welco...

Galapagos stops CAR-T cell treatment trial over Parkinsonism instance

.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushing the b...

James Wilson leaving Penn to release pair of brand new biotechs

.After more than thirty years, gene treatment trailblazer James Wilson M.D., Ph.D., is actually leav...

3 biotechs make an effort to defeat the summer warm through dropping staff

.As biotechs attempt to turn a new page in August, a minimum of three firms have dropped staff in tr...

venBio elevates $528M for 5th lifestyle scientific researches VC fund

.Veteran financial backing organization venBio has actually lifted one more half a billion bucks to ...